Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Change in Intangibles (2019 - 2022)

Sanara MedTech (SMTI) has disclosed Change in Intangibles for 4 consecutive years, with -$1.5 million as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Change in Intangibles fell 351.25% year-over-year to -$1.5 million, compared with a TTM value of -$1.5 million through Sep 2025, changed N/A, and an annual FY2024 reading of $23452.0, changed N/A over the prior year.
  • Change in Intangibles was -$1.5 million for Q3 2022 at Sanara MedTech, down from $578586.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $1.0 million in Q3 2019 and bottomed at -$1.5 million in Q3 2022.
  • Average Change in Intangibles over 4 years is $291224.8, with a median of $539293.0 recorded in 2019.
  • Peak annual rise in Change in Intangibles hit 351.25% in 2022, while the deepest fall reached 351.25% in 2022.
  • Year by year, Change in Intangibles stood at $500000.0 in 2019, then increased by 20.0% to $600000.0 in 2020, then dropped by 3.57% to $578586.0 in 2021, then tumbled by 351.25% to -$1.5 million in 2022.
  • Business Quant data shows Change in Intangibles for SMTI at -$1.5 million in Q3 2022, $578586.0 in Q3 2021, and $600000.0 in Q2 2020.